FDA issues final guidelines on incorporating human genome editing in gene therapy products
Xuening Huang2024-07-10T19:46:03+00:00The guidance provides recommendations regarding information that should be provided in an investigational new drug (IND) application to assess the safety and quality of the investigational GE product, including information on product design, product manufacturing and testing, nonclinical safety...